Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Very late prostate cancer local recurrence 23 years after radical prostatectomy.

Liedberg F, Olsson H, Sundqvist P.

Scand J Urol Nephrol. 2012 Aug;46(4):304-5. doi: 10.3109/00365599.2012.663406. Epub 2012 Mar 1.

PMID:
22375585
2.

Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW.

J Urol. 2006 Oct;176(4 Pt 1):1404-8.

PMID:
16952644
3.
4.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
5.

Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.

J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. Epub 2007 Aug 14.

PMID:
17698121
6.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

7.

Long-term follow-up and risk of cancer death after radiation for post-prostatectomy rising prostate-specific antigen.

Swanson GP, Du F, Michalek JE, Hermans M.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):62-8. doi: 10.1016/j.ijrobp.2010.01.043. Epub 2010 Jun 18.

PMID:
20646861
8.

Clinicopathological features of patients with biochemical recurrence after radical prostatectomy without progressive rise in serum prostate-specific antigen.

Miyake H, Hara I, Kurahashi T, Muramaki M, Yamanaka K, Inoue TA, Fujisawa M.

Urol Int. 2006;77(3):200-4.

PMID:
17033205
10.

The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number.

Ploussard G, Azancot V, Nicolaiew N, Xylinas E, Salomon L, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A.

BJU Int. 2010 Nov;106(9):1293-7. doi: 10.1111/j.1464-410X.2010.09361.x.

12.

Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.

Walsh PC.

J Urol. 2005 Oct;174(4 Pt 1):1500-1; author reply 1501. No abstract available.

PMID:
16145486
13.

Impact of patient age on biochemical recurrence rates following radical prostatectomy.

Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.

J Urol. 2007 Nov;178(5):1933-7; discussion 1937-8. Epub 2007 Sep 17.

PMID:
17868723
15.

Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.

Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC Jr.

Urology. 2010 Feb;75(2):439-44. doi: 10.1016/j.urology.2009.06.089. Epub 2009 Oct 12.

PMID:
19819536
16.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
17.

Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.

Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA.

J Urol. 2006 Aug;176(2):564-8.

PMID:
16813890
18.

The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.

Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.

Hum Pathol. 2007 Aug;38(8):1207-11. Epub 2007 May 8.

PMID:
17490720
20.

[Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].

Kanno H, Umemoto S, Izumi K, Hasumi H, Osada Y, Ohta J, Mikata K, Tuchiya F.

Nihon Hinyokika Gakkai Zasshi. 2006 May;97(4):649-59. Japanese.

Supplemental Content

Support Center